Clinical Medicine and Diagnostics

Clinical Medicine and Diagnostics is a peer-reviewed journal publishing papers of significance in all areas of medical sciences. Articles include original research papers, reviews and short research communications. Submissions of basic and clinical research are both considered.

Aini Xie

Post-doctoral Fellow, Houston Methodist Research Institute, USA

Research Areas



2007-2010Ph.D.Huazhong University of Science and Technology
1997-2002M.DHuazhong University of Science and Technology


2013-presentPostdoctoral,Houston Methodist Hospital
2012-2013Postdoctoral,Baylor college of medicine
2011-2012Postdoctoral,University of Toledo
2008-2011Attending physician,Union Hospital, Huazhong University of Science and Technology
2005-2008Resident physician,Union Hospital, Huazhong University of Science and Technology

Publications: Journals

[1]  Xie A, Wang S, Zhang K, et al. Treatment with interleukin-12/23p40 antibody attenuates acute cardiac allograft rejection. Transplantation, 2011, 91(1):27-34. (CI 15).
[2]  Aini Xie, Eric Dale Buras, Jiahong Xia , et al. The Emerging Role of Interleukin-21 in Transplantation, J Clin Cell Immunol, 2012, S9: 002
[3]  Xie AN, Dong NG, Zhang KL, Xia JH, Xiao SL, Sun ZQ. Clinical experience in the use of marginal donor hearts. Chin Med J (Engl). 2011 Apr; 124(8):1185-8.
[4]  Wang S, Li J, Xie A, et al. Dynamic changes in Th1, Th17, and FoxP3(+) T cells in patients with acute cellular rejection after cardiac transplantation. Clin Transplant, 2011, 25(3):177- 186
[5]  Ye P, Li J, Wang S, Xie A, et al. Eicosapentaenoic acid disrupts the balance between Tregs and IL-17+ T cells through PPARγ nuclear receptor activation and protects cardiac allografts. J Surg Res. 2012, 173(1):161-70
[6]  Xia Jiahong, Xie Aini, et al. The vascular endothelial growth factor expression and vascular regeneration in infarcted myocardium by skeletal muscle satellite cells. Chin Med J, 2006,119(2): 117-121
[7]  Wang S, Xu X, Xie A, et al. Anti-interleukin-12/23p40 antibody attenuates chronic rejection of cardiac allografts partly via inhibition δT cells. Clinical & Experimental Immunology, 2012, 169(3):320-329.
[8]  Chen W, Xie A, Chan L. Mechanistic basis of immunotherapies for type 1 diabetes mellitus. Transl Res. 2013, 161(4):217-29
[9]  Schroder PM, Khattar M, Deng R, Xie A, Chen W, Stepkowski SM.Transient Combination Therapy Targeting the Immune Synapse Abrogates T Cell Responses and Prolongs Allograft Survival in Mice , PLoS One. 2013 Jul 24;8(7):e69397.